Half year results 2011 (Roche) - Jul 21, 2011 - mericitabine (RG7128) / Roche; Anticipated P2b final data PROPEL for HCV 1 and 4 in H2 '11; Anticipated P2b JUMP-C data for HCV 1 & 4 in H2 '11; Anticipated NME submission for HCV in 2013; Anticipated P2b MATTERHORN FPI for HCV in Q2 '11
Anticipated NME submission • Anticipated P2 enrollment initiation • Anticipated P2b data • Hepatitis C Virus • None
|